Understanding when to give adenosine in ACLS is one of the most high-yield clinical decisions you will face on your certification exam and in real resuscitation scenarios. Adenosine is the first-line agent for stable supraventricular tachycardia (SVT) with a narrow complex and a regular rhythm, administered as a rapid 6 mg IV push followed by a 20 mL saline flush. If conversion does not occur within one to two minutes, a second dose of 12 mg is given. Getting this decision right requires mastery of the full library of acls algorithms and medications that govern every major cardiac emergency.

ACLS — Advanced Cardiovascular Life Support — is a structured set of evidence-based protocols developed by the American Heart Association (AHA). These protocols guide healthcare providers through cardiac arrest, post-resuscitation care, acute coronary syndromes, stroke, and dysrhythmia management. Whether you are a registered nurse, paramedic, respiratory therapist, or physician, ACLS certification requires you to demonstrate competency with both the decision algorithms and the pharmacology behind each intervention. The exam tests scenario-based reasoning, not simple memorization.

The ACLS algorithm library covers six major clinical scenarios: cardiac arrest with VF/pVT, cardiac arrest with PEA and asystole, post-cardiac arrest care, tachycardia (stable and unstable), bradycardia, and acute coronary syndrome. Each algorithm specifies which drugs to give, in what order, at what dose, and under what conditions. Mastering this interconnected system is the central challenge of ACLS prep. Many candidates underestimate how much pharmacology is embedded in the algorithms themselves.

The pharmacology side of ACLS spans over a dozen medications, each with a specific indication, dose, route, and contraindication profile. Epinephrine, amiodarone, atropine, adenosine, lidocaine, dopamine, norepinephrine, magnesium sulfate, sodium bicarbonate, calcium chloride, and vasopressin all appear on the exam in various clinical contexts. A provider who cannot quickly recall the correct dose and timing for each agent will struggle both on the test and in a real code situation where seconds matter.

This study guide is organized to help you build a systematic, layered understanding of ACLS content. We will walk through the major algorithms, break down the most commonly tested medications with their doses and indications, explain the tachycardia decision tree in detail (including when adenosine is appropriate versus when it is not), cover bradycardia management, and provide exam strategy tips. Each section is designed to reinforce clinical reasoning rather than rote recall.

Practice testing is a critical component of ACLS prep because the exam emphasizes scenario application. Reading algorithms is necessary but not sufficient — you need to practice reading a clinical vignette, identifying the rhythm or condition, selecting the correct algorithm branch, and naming the right drug and dose under time pressure. This guide pairs conceptual content with direct links to practice quizzes so you can reinforce each section immediately after studying it.

Whether you are preparing for your initial ACLS certification or renewing after two years, this guide covers the core content domains assessed on the AHA written exam and the megacode skills station. By the time you finish, you will have a clear mental map of every major algorithm, every key drug, and the clinical logic connecting them — so you can perform with confidence in the exam room and at the bedside.

The ACLS medication list can feel overwhelming at first glance, but the drugs group logically by the algorithm in which they appear. In the cardiac arrest algorithm for VF and pulseless VT, the two pharmacologic workhorses are epinephrine 1 mg IV/IO every 3 to 5 minutes and amiodarone 300 mg IV/IO for the first dose, with a second dose of 150 mg if the rhythm persists. Lidocaine 1 to 1.5 mg/kg IV/IO is an acceptable alternative to amiodarone when amiodarone is unavailable. These three agents address the electrophysiologic chaos of ventricular fibrillation and pulseless ventricular tachycardia.

For PEA and asystole, epinephrine 1 mg IV/IO every 3 to 5 minutes remains the only pharmacologic ACLS intervention. The emphasis in these rhythms shifts heavily toward identifying and treating reversible causes — the Hs and Ts. The eight Hs are hypovolemia, hypoxia, hydrogen ion (acidosis), hypo/hyperkalemia, hypothermia, hypoglycemia, hypoventilation, and hyperthermia. The eight Ts are tension pneumothorax, tamponade (cardiac), toxins, thrombosis (pulmonary), thrombosis (coronary), trauma, tachycardia, and tachyarrhythmia. Knowing these by memory is essential for both the written exam and the megacode.

Atropine is the primary drug for symptomatic bradycardia, dosed at 0.5 mg IV every 3 to 5 minutes to a maximum of 3 mg. It works by blocking vagal tone on the SA and AV nodes. However, atropine is not effective for high-degree AV block at the level of the His-Purkinje system. In those cases — or when atropine fails — providers should move to transcutaneous pacing, dopamine infusion at 2 to 20 mcg/kg/min, or epinephrine infusion at 2 to 10 mcg/min. Recognizing when atropine will and will not work is a classic exam trap that many candidates miss.

Magnesium sulfate is one of the most underappreciated ACLS medications. It is indicated for torsades de pointes (polymorphic VT associated with a prolonged QT interval), given as 1 to 2 grams IV push. It is also considered in refractory VF, particularly when hypomagnesemia is suspected. Calcium chloride 1 gram IV is indicated for hyperkalemia, hypocalcemia, and calcium-channel blocker toxicity. Sodium bicarbonate 1 mEq/kg IV is reserved for pre-existing metabolic acidosis, hyperkalemia, and tricyclic antidepressant overdose — not as a routine arrest drug.

Vasopressin was previously listed in ACLS guidelines as an alternative to the first or second dose of epinephrine, but the 2015 AHA update removed it from the algorithm because evidence did not demonstrate superiority over epinephrine. However, some exam questions still reference vasopressin in legacy contexts, and it remains used in some clinical settings at 40 units IV/IO as a one-time dose. Knowing this history can help you answer tricky questions that bridge old and new guidelines.

Dopamine and norepinephrine are the main vasopressors used in post-cardiac arrest care and in hemodynamically unstable bradycardia or hypotension. Dopamine at low doses (2 to 5 mcg/kg/min) has primarily dopaminergic effects; at moderate doses (5 to 15 mcg/kg/min) it adds beta-1 inotropic effects; at higher doses it becomes predominantly alpha-adrenergic. Norepinephrine infusion at 0.1 to 0.5 mcg/kg/min is preferred for septic shock and post-arrest hypotension when systolic BP remains below 90 mmHg despite fluids. Understanding the dose-response relationship of dopamine is a recurring exam theme.

Finally, oxygen and airway management are pharmacologic and procedural cornerstones of every ACLS algorithm. High-flow oxygen via bag-valve mask or advanced airway should be initiated immediately in any arrested or compromised patient. After ROSC (return of spontaneous circulation), oxygen should be titrated to maintain SpO2 between 94 and 99 percent — hyperoxia after resuscitation is associated with worse neurologic outcomes. This titration principle reflects the nuanced, evidence-based thinking that ACLS exams increasingly emphasize over simple memorization of drug names.

Adenosine's mechanism of action is what makes it both uniquely effective and uniquely dangerous in the wrong context. It works by transiently blocking conduction through the AV node, breaking the re-entry circuit that sustains most SVTs.

Because the effect lasts only 10 to 30 seconds — adenosine has an extremely short half-life due to rapid uptake by red blood cells and vascular endothelium — side effects are brief and include facial flushing, chest tightness, a sense of impending doom, and a transient asystolic pause that can be alarming to both patient and team. Patients should be warned about these sensations before the drug is given.

The administration technique for adenosine is critically specific and differs from almost every other ACLS drug. It must be given as a rapid IV bolus directly into a large antecubital or central vein, followed immediately by a 20 mL saline flush to drive the drug centrally before it is degraded.

A slow push or administration through a peripheral hand or foot IV dramatically reduces effectiveness because the drug is cleared before reaching the heart in therapeutic concentrations. This is a classic exam question: "What is the correct technique for adenosine administration?" — and the answer always emphasizes rapid push and immediate flush.

Adenosine is also used diagnostically. When a wide-complex tachycardia is of uncertain origin, adenosine can sometimes help distinguish SVT with aberrancy from VT. If the rhythm converts with adenosine, it was almost certainly SVT. If it does not convert but the ventricular rate slows temporarily, it may reveal underlying flutter waves, confirming atrial flutter with block.

However, this diagnostic use comes with risk in patients whose wide-complex tachycardia might be VT — adenosine generally does not harm VT patients but also does not help them, and the transient AV block can unmask hemodynamic instability. The AHA recommends this diagnostic use only in stable patients with a clear clinical indication.

The dosing sequence for adenosine — 6 mg, then 12 mg, then 12 mg — is non-negotiable on the ACLS exam. The first dose of 6 mg is chosen because a higher initial dose would cause unnecessary side effects in patients whose SVT might convert at the lower dose. If the first dose fails, 12 mg is administered after one to two minutes.

A third dose of 12 mg may be given if the second fails. At this point, if the rhythm has not converted, the algorithm directs providers to consider other causes and agents such as calcium channel blockers (diltiazem or verapamil) or beta-blockers for rate control, or to reassess whether the patient has become unstable and now requires cardioversion.

Patients taking dipyridamole or carbamazepine require lower doses of adenosine because these drugs potentiate its effects by blocking cellular reuptake. Conversely, patients on methylxanthines (theophylline or caffeine) may require higher doses because these compounds competitively antagonize the adenosine receptor. These drug interactions are tested on the pharmacology portion of the ACLS exam and reflect the growing emphasis on medication reconciliation in resuscitation scenarios.

One subtle but important point about adenosine that separates high scorers from average ones: adenosine should NOT be given for SVT in patients who are hemodynamically unstable. If the patient with SVT has a blood pressure of 80/50 mmHg, altered consciousness, or pulmonary edema, the correct intervention is immediate synchronized cardioversion — not adenosine. The tachycardia algorithm has two branches for exactly this reason. Many candidates memorize "adenosine for SVT" without attaching the critical qualifier "stable SVT." On the exam, the stability assessment always comes first.

Finally, the distinction between adenosine and the drugs used for rate control in atrial fibrillation and atrial flutter deserves emphasis. Adenosine does not convert AF or flutter to sinus rhythm — these rhythms are maintained by mechanisms other than simple AV nodal re-entry. For rate control in AF/flutter in a stable patient, the AHA recommends diltiazem or a beta-blocker.

For rhythm conversion of hemodynamically stable AF in a patient with structurally normal heart, IV ibutilide or oral flecainide are pharmacologic options outside the core ACLS algorithm. Knowing these boundaries — what adenosine does and does not treat — is the foundation of excellent ACLS pharmacology reasoning.

Exam strategy for ACLS is as important as content knowledge. The AHA written exam consists of approximately 50 multiple-choice questions covering all content domains: basic life support, cardiac arrest algorithms, pharmacology, rhythm recognition, acute coronary syndrome, and post-resuscitation care. A passing score is typically 84 percent or higher — meaning you can miss no more than 8 questions. This tight margin means you cannot afford to be vague on any major topic area. Targeted, systematic review combined with frequent practice testing is the most efficient preparation strategy.

The single most effective study habit for ACLS is working through case scenarios from start to finish, not just reviewing isolated facts. When you read "Patient has SVT at 180 bpm, BP 110/70, no chest pain" — you should mentally step through the entire algorithm in sequence: Is the patient stable? Yes. Is the QRS narrow? Yes. Is it regular? Yes.

Have vagal maneuvers been tried? Then adenosine 6 mg rapid IV push. This habit of sequential clinical reasoning is what the megacode evaluates, and building it during written prep pays dividends in both exam settings. Reviewing your complete acls algorithms and medications knowledge systematically in this way is the most efficient path to a passing score.

Rhythm recognition deserves special emphasis because it is embedded in every algorithm decision. You cannot choose the right treatment without correctly identifying the rhythm. On the exam, you will be shown ECG strips and asked to identify the rhythm or to determine the appropriate next action. The rhythms most commonly tested include sinus bradycardia, sinus tachycardia, SVT (narrow regular), atrial fibrillation (narrow irregular), atrial flutter with regular block, ventricular tachycardia (wide regular), ventricular fibrillation, PEA (organized rhythm without pulse), and asystole. Spending dedicated time on ECG strips — not just algorithm flowcharts — pays significant dividends on exam day.

Time management during the exam is straightforward if you have practiced adequately. Budget about one minute per question, flag any question you are uncertain about, and return to flagged questions after completing the rest. Most candidates finish with time to spare. The bigger risk is second-guessing correct first instincts on pharmacology questions — if you recall the adenosine dose as 6 mg and the case clearly describes stable SVT, trust your knowledge and move on. Overanalyzing clear-cut drug dosing questions is a common source of preventable errors.

The megacode station is assessed by an AHA instructor who evaluates your performance as team leader in a simulated cardiac arrest scenario. You will be expected to direct team members to perform CPR, apply the defibrillator, establish IV access, administer medications, and manage the airway — all while calling out the correct drug names, doses, and timing. Closed-loop communication (where the team leader states the order, the team member confirms the order, and reports back when complete) is explicitly evaluated. Practice these communication patterns out loud during your preparation, not just mentally.

One area candidates consistently under-prepare is post-cardiac arrest care. After ROSC is achieved, the algorithm shifts to optimizing organ perfusion and preventing secondary injury. Key targets include: SpO2 94 to 99 percent (avoiding hyperoxia), ETCO2 35 to 45 mmHg (normocapnia), systolic BP at least 90 mmHg or MAP at least 65 mmHg, and targeted temperature management at 32 to 36 degrees Celsius for comatose survivors.

A 12-lead ECG should be obtained immediately after ROSC to detect STEMI, which if present requires urgent catheterization lab activation. These post-ROSC management questions appear on the written exam and are often missed by candidates who focus exclusively on the arrest phase.

Building a study group with colleagues preparing for the same ACLS certification date is one of the highest-value strategies available. Group study enables megacode simulation with realistic team dynamics, mutual quizzing on drug doses and contraindications, and peer explanation of concepts — which is proven to consolidate learning more effectively than solo review. If a study group is not feasible, use practice exams and the AHA provider manual's pre-course self-assessment to identify your weakest content domains and direct your remaining study time accordingly. Active retrieval through practice testing outperforms passive re-reading by a wide margin for exam performance.

Practical preparation for ACLS certification comes down to a handful of habits that separate candidates who pass confidently from those who barely scrape by. The first habit is building a personal drug card with every ACLS medication, its indication, dose, route, timing, and top contraindication on one side, and the algorithm it appears in on the other.

Writing this card by hand from memory — not copying it from the manual — is a powerful recall exercise. Review it every morning during your final two weeks of prep. Many providers who have been working in healthcare for years are surprised by how many doses they have been carrying slightly wrong.

The second high-yield habit is practicing ECG interpretation daily using flashcard apps or rhythm strips from free online repositories. Five minutes of rhythm strips per day for three weeks produces dramatic improvement in recognition speed. On exam day, you will immediately recognize rhythms that used to require deliberate analysis, freeing up cognitive bandwidth for the more complex scenario-based questions. Focus particularly on distinguishing SVT from sinus tachycardia (the P waves differ), VT from SVT with aberrancy (history and onset matter), and third-degree AV block from complete dissociation (consistent P-P interval with independent QRS rate).

Drill the Hs and Ts until they are automatic. These 16 reversible causes of cardiac arrest are tested repeatedly in PEA and asystole scenarios. The exam will describe clinical features pointing toward a specific cause — peaked T waves suggesting hyperkalemia, narrow pulse pressure and muffled heart sounds suggesting tamponade, unilateral absent breath sounds suggesting tension pneumothorax, recent ingestion suggesting toxins — and you must map those clues to the correct Hs and Ts category and treatment.

Hyperkalemia is treated with calcium chloride and sodium bicarbonate; tamponade requires needle decompression; tension pneumothorax requires needle thoracostomy. These clinical reasoning chains should be memorized as complete sequences.

Do not neglect the acute coronary syndrome (ACS) section, even though it sometimes feels peripheral to the cardiac arrest focus. ACLS exams test the recognition of STEMI, the appropriate use of aspirin 324 mg, nitroglycerin for ischemic chest pain (contraindicated when systolic BP is below 90 mmHg or with PDE-5 inhibitor use in the last 24-48 hours), and the decision to activate the cath lab versus administer fibrinolytics based on transfer time and contraindications.

A well-prepared candidate knows both the pharmacology and the time targets: door-to-balloon time under 90 minutes for PCI or fibrinolytics within 30 minutes when PCI is not available within 120 minutes.

On the morning of your exam, avoid cramming new information. Your brain consolidates learning during sleep, and last-minute review of unfamiliar material is more likely to create confusion than to add useful knowledge. Instead, review your drug card once, mentally walk through each of the six major algorithms in sequence, and remind yourself of the key branch points — stable versus unstable, shockable versus non-shockable, narrow versus wide, regular versus irregular. These six binary decisions drive the majority of correct ACLS choices and serve as an efficient final mental review.

After you pass your initial ACLS certification, maintain your competency through the two-year validity period. Many providers find that their drug dose recall degrades within 12 to 18 months without intentional refresher activity. Annual review of the AHA algorithm updates, participation in code simulations at your facility, and periodic completion of ACLS practice tests are the most effective maintenance strategies.

The AHA updates ACLS guidelines every five years, with the most recent major revision in 2020 and incremental updates since. Staying current with guideline changes — particularly around post-cardiac arrest care and the role of newer vasopressors — ensures your knowledge remains examination-ready and clinically current when your renewal date arrives.

Finally, approach ACLS certification not as a hurdle to clear but as a clinical competency worth genuinely owning. The providers who perform best in actual codes are those who internalized the algorithms so deeply that they can execute under the cognitive load of a real emergency — when family members are watching, when the defibrillator is not charging properly, when a team member gives the wrong dose.

That level of mastery comes from the same systematic preparation described throughout this guide: repeated scenario practice, active recall of drug doses, ECG drilling, and honest self-assessment of weak areas. The exam is simply a structured checkpoint on the way to that deeper competency.